Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

Active, not recruitingOBSERVATIONAL

Enrollment

272

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)

Trial Locations (1)

Jiangxi Cancer Hospital, Nanchang

All Listed Sponsors

lead

Qiang Xu

OTHER